$197 Million is the total value of Altium Capital Management LP's 94 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 70.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | ASTRIA THERAPEUTICS INC | $20,181,489 | +401.7% | 1,355,372 | +204.6% | 10.26% | +595.3% | |
| ADMA | Sell | ADMA BIOLOGICS INC | $11,135,600 | +58.9% | 2,870,000 | -0.5% | 5.66% | +120.3% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $10,087,000 | -2.3% | 385,000 | -26.7% | 5.13% | +35.5% |
| BLU | BELLUS HEALTH INC NEW | $9,305,040 | -22.2% | 1,132,000 | 0.0% | 4.73% | +7.9% | |
| PEPPERLIME HEALTH ACQUSTN CO | $7,504,350 | +2.2% | 735,000 | 0.0% | 3.81% | +41.7% | ||
| AKRO | Sell | AKERO THERAPEUTICS INC | $6,850,000 | +43.7% | 125,000 | -10.7% | 3.48% | +99.1% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $6,426,750 | +4.9% | 1,025,000 | -41.4% | 3.27% | +45.4% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $5,617,950 | +36.1% | 215,000 | -46.8% | 2.86% | +88.6% |
| ITCI | INTRA-CELLULAR THERAPIES INC | $5,292,000 | +13.7% | 100,000 | 0.0% | 2.69% | +57.6% | |
| Buy | AMYLYX PHARMACEUTICALS INC | $5,173,000 | +425.2% | 140,000 | +300.0% | 2.63% | +628.3% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $4,950,400 | +18.9% | 170,000 | 0.0% | 2.52% | +64.8% | |
| Buy | ARCELLX INC | $4,647,000 | +115.2% | 150,000 | +30.4% | 2.36% | +198.2% | |
| REPL | New | REPLIMUNE GROUP INC | $4,352,000 | – | 160,000 | +100.0% | 2.21% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $4,323,000 | +13.0% | 22,000 | +29.4% | 2.20% | +56.7% |
| XTNT | XTANT MED HLDGS INC | $4,122,552 | -8.3% | 6,246,291 | 0.0% | 2.10% | +27.1% | |
| ISEE | Buy | IVERIC BIO INC | $4,067,900 | +81.4% | 190,000 | +52.0% | 2.07% | +151.5% |
| TNDM | New | TANDEM DIABETES CARE INC | $4,045,500 | – | 90,000 | +100.0% | 2.06% | – |
| GKOS | Sell | GLAUKOS CORP | $3,974,880 | -23.0% | 91,000 | -6.2% | 2.02% | +6.7% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $3,862,600 | -12.6% | 620,000 | -6.0% | 1.96% | +21.1% |
| OTLK | New | OUTLOOK THERAPEUTICS INC | $3,593,596 | – | 3,327,404 | +100.0% | 1.83% | – |
| RMD | RESMED INC | $3,538,210 | -4.7% | 17,000 | 0.0% | 1.80% | +32.1% | |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $3,158,100 | -9.2% | 330,000 | +11.5% | 1.60% | +25.9% |
| QTRX | Buy | QUANTERIX CORP | $3,113,480 | +197.4% | 224,800 | +136.6% | 1.58% | +312.0% |
| MYGN | Buy | MYRIAD GENETICS INC | $3,076,120 | -13.3% | 212,000 | +14.0% | 1.56% | +20.1% |
| KRMD | Sell | KORU MEDICAL SYSTEMS INC | $3,052,350 | +37.5% | 855,000 | -14.1% | 1.55% | +90.5% |
| NVRO | Buy | NEVRO CORP | $3,009,600 | +0.9% | 76,000 | +18.8% | 1.53% | +39.9% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $2,985,700 | – | 365,000 | +100.0% | 1.52% | – |
| New | BIOHAVEN LTD | $2,776,000 | – | 200,000 | +100.0% | 1.41% | – | |
| CTIC | Buy | CTI BIOPHARMA CORP | $2,704,500 | +8.8% | 450,000 | +5.4% | 1.37% | +50.8% |
| SIBN | Buy | SI-BONE INC | $2,652,000 | -9.1% | 195,000 | +16.8% | 1.35% | +26.1% |
| NEO | New | NEOGENOMICS INC | $2,633,400 | – | 285,000 | +100.0% | 1.34% | – |
| CARA | Buy | CARA THERAPEUTICS INC | $2,104,610 | +16.5% | 195,960 | +1.5% | 1.07% | +61.6% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,090,200 | +3.6% | 17,500 | -7.9% | 1.06% | +43.5% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $2,088,000 | +12.4% | 90,000 | -22.4% | 1.06% | +55.8% |
| PCVX | New | VAXCYTE INC | $2,061,850 | – | 43,000 | +100.0% | 1.05% | – |
| TG VENTURE ACQUISITION CORPunit 08/15/2028 | $2,038,000 | +0.9% | 200,000 | 0.0% | 1.04% | +39.8% | ||
| PLRX | Sell | PLIANT THERAPEUTICS INC | $1,933,000 | -57.0% | 100,000 | -53.5% | 0.98% | -40.4% |
| SAGE | New | SAGE THERAPEUTICS INC | $1,907,000 | – | 50,000 | +100.0% | 0.97% | – |
| BLRX | Sell | BIOLINERX LTDsponsored ads | $1,831,145 | -52.3% | 3,103,635 | -25.2% | 0.93% | -33.8% |
| AULT DISRUPTIVE TECHS CORP | $1,537,500 | +1.7% | 150,000 | 0.0% | 0.78% | +41.0% | ||
| New | TG THERAPEUTICS INCcall | $1,183,000 | – | 100,000 | +100.0% | 0.60% | – | |
| New | SYROS PHARMACEUTICALS INC | $1,131,101 | – | 315,070 | +100.0% | 0.58% | – | |
| WESTERN ACQSTN VENTURES CORPunit 09/01/2026 | $1,100,000 | +8.9% | 100,000 | 0.0% | 0.56% | +51.1% | ||
| MURPHY CANYON ACQUISITION COunit 01/25/2027 | $1,018,000 | +1.4% | 100,000 | 0.0% | 0.52% | +40.5% | ||
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $1,010,000 | +1.9% | 100,000 | 0.0% | 0.51% | +41.3% | |
| COLISEUM ACQUISITION CORP | $853,400 | +2.2% | 85,000 | 0.0% | 0.43% | +41.8% | ||
| TSHA | New | TAYSHA GENE THERAPIES INC | $811,455 | – | 359,051 | +100.0% | 0.41% | – |
| New | SOMALOGIC INC | $778,100 | – | 310,000 | +100.0% | 0.40% | – | |
| HYRE | New | HYRECAR INC | $715,763 | – | 1,688,120 | +100.0% | 0.36% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $712,600 | – | 70,000 | +100.0% | 0.36% | – |
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $683,270 | -41.7% | 227,000 | 0.0% | 0.35% | -19.1% | |
| New | RXSIGHT INC | $640,925 | – | 50,586 | +100.0% | 0.33% | – | |
| GOED | New | POLISHED COM INC | $578,174 | – | 1,000,821 | +100.0% | 0.29% | – |
| PEPGEN INC | $534,800 | +47.3% | 40,000 | 0.0% | 0.27% | +104.5% | ||
| GSR II METEORA ACQUISITN CORunit 02/24/2027 | $528,500 | +2.8% | 50,000 | 0.0% | 0.27% | +43.1% | ||
| DOUBLEDOWN INTERACTIVE CO LTads | $514,402 | -8.5% | 60,876 | 0.0% | 0.26% | +26.7% | ||
| Sell | OPY ACQUISITION CORP I | $501,000 | -49.5% | 50,000 | -50.0% | 0.26% | -29.9% | |
| CLBR | COLOMBIER ACQUISITION CORPcl a | $497,000 | +1.8% | 50,000 | 0.0% | 0.25% | +41.3% | |
| GOEDWS | POLISHED COM INC*w exp 06/02/202 | $488,306 | -36.0% | 6,103,824 | 0.0% | 0.25% | -11.4% | |
| New | MEDIWOUND LTD | $368,088 | – | 27,286 | +100.0% | 0.19% | – | |
| KURA | New | KURA ONCOLOGY INC | $349,937 | – | 28,198 | +100.0% | 0.18% | – |
| New | ABEONA THERAPEUTICS INC | $334,784 | – | 108,696 | +100.0% | 0.17% | – | |
| TRKA | New | TROIKA MEDIA GROUP INC | $310,026 | – | 2,672,640 | +100.0% | 0.16% | – |
| ZEV | New | LIGHTNING EMOTORS INC | $213,249 | – | 581,852 | +100.0% | 0.11% | – |
| WEARABLE DEVICES LTD*w exp 09/14/202 | $171,086 | -42.0% | 1,411,600 | 0.0% | 0.09% | -19.4% | ||
| DIRECT DIGITAL HOLDINGS INC*w exp 02/15/202 | $140,400 | +186.5% | 180,000 | 0.0% | 0.07% | +294.4% | ||
| New | ASTRIA THERAPEUTICS INCcall | $114,653 | – | 7,700 | +100.0% | 0.06% | – | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $99,800 | +0.8% | 10,000 | 0.0% | 0.05% | +41.7% | |
| Buy | JEFFS BRANDS LTD*w exp 08/26/202 | $79,327 | +98.3% | 480,770 | +100.0% | 0.04% | +166.7% | |
| CINGULATE INC*w exp 12/10/202 | $64,827 | +9.9% | 270,000 | 0.0% | 0.03% | +50.0% | ||
| ONFOLIO HOLDINGS INC*w exp 01/02/202 | $48,000 | +60.0% | 200,000 | 0.0% | 0.02% | +118.2% | ||
| MBTCR | NOCTURNE ACQUISITION CORPright 12/26/2025 | $38,900 | +76.8% | 500,000 | 0.0% | 0.02% | +150.0% | |
| HARBOR CUSTOM DEVELOPMENT IN*w exp 10/07/202 | $38,935 | -65.8% | 650,000 | 0.0% | 0.02% | -52.4% | ||
| NLSPW | NLS PHARMACEUTICS LTD*w exp 02/02/202 | $38,010 | -11.6% | 200,000 | 0.0% | 0.02% | +18.8% | |
| NEXGEL INC*w exp 12/01/202 | $33,750 | -50.4% | 225,000 | 0.0% | 0.02% | -32.0% | ||
| ZEVWS | LIGHTNING EMOTORS INC*w exp 05/18/202 | $25,304 | -78.9% | 652,173 | 0.0% | 0.01% | -70.5% | |
| PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202 | $24,071 | -10.8% | 367,500 | 0.0% | 0.01% | +20.0% | ||
| CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999 | $21,705 | +210.1% | 150,000 | 0.0% | 0.01% | +266.7% | ||
| NEXALIN TECHNOLOGY INC*w exp 09/15/202 | $21,000 | +10.5% | 105,000 | 0.0% | 0.01% | +57.1% | ||
| CEA INDUSTRIES INC*w exp 02/11/202 | $22,500 | -40.8% | 250,000 | 0.0% | 0.01% | -21.4% | ||
| New | TILRAY BRANDS INCcall | $20,444 | – | 7,600 | +100.0% | 0.01% | – | |
| Buy | BRUUSH ORAL CARE INC*w exp 08/03/202 | $19,543 | -62.4% | 360,579 | +200.0% | 0.01% | -47.4% | |
| INNOVATIVE EYEWEAR INC*w exp 08/16/202 | $18,345 | -69.4% | 150,000 | 0.0% | 0.01% | -59.1% | ||
| HCDIW | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $17,400 | -80.9% | 600,000 | 0.0% | 0.01% | -72.7% | |
| New | DIGITAL HEALTH ACQUISITION C*w exp 11/02/202 | $14,835 | – | 150,000 | +100.0% | 0.01% | – | |
| New | PROSOMNUS INC*w exp 04/20/202 | $11,790 | – | 150,000 | +100.0% | 0.01% | – | |
| New | SELINA HOSPITALITY PLC*w exp 10/27/202 | $8,115 | – | 101,439 | +100.0% | 0.00% | – | |
| SURROZEN INC*w exp 08/01/203 | $7,023 | -53.2% | 82,233 | 0.0% | 0.00% | -20.0% | ||
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $7,413 | +48.3% | 133,333 | 0.0% | 0.00% | +100.0% | |
| OPY ACQUISITION CORP I*w exp 09/22/202 | $3,225 | -35.5% | 50,000 | 0.0% | 0.00% | 0.0% | ||
| New | RELATIVITY ACQUISITION CORP*w exp 12/15/202 | $3,010 | – | 100,000 | +100.0% | 0.00% | – | |
| COLISEUM ACQUISITION CORP*w exp 08/22/202 | $2,026 | +1.3% | 28,333 | 0.0% | 0.00% | 0.0% | ||
| CLBRWS | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $1,433 | -28.4% | 16,666 | 0.0% | 0.00% | 0.0% | |
| Sell | TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $1,684 | -98.6% | 18,823 | -98.0% | 0.00% | -97.7% | |
| TMPMW | Exit | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $0 | – | -84,666 | -100.0% | -0.00% | – |
| Exit | INDUSTRIAL HUMAN CAPITAL INC*w exp 11/27/202 | $0 | – | -100,000 | -100.0% | -0.00% | – | |
| SRSAW | Exit | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $0 | – | -75,000 | -100.0% | -0.00% | – |
| Exit | GIGINTERNATIONAL1 INC*w exp 04/19/202 | $0 | – | -50,000 | -100.0% | -0.00% | – | |
| Exit | AULT DISRUPTIVE TECHS CORP*w exp 99/99/999 | $0 | – | -112,500 | -100.0% | -0.00% | – | |
| Exit | LAKESHORE ACQUISITION I CORP*w exp 07/15/202 | $0 | – | -150,000 | -100.0% | -0.01% | – | |
| Exit | RENOVACOR INC*w exp 99/99/999 | $0 | – | -731,561 | -100.0% | -0.02% | – | |
| NBY | Exit | NOVABAY PHARMACEUTICALS INC | $0 | – | -1,095,957 | -100.0% | -0.04% | – |
| Exit | VIGIL NEUROSCIENCE INC | $0 | – | -15,788 | -100.0% | -0.05% | – | |
| Exit | TWIN VEE POWERCATS CO | $0 | – | -67,798 | -100.0% | -0.06% | – | |
| BNTC | Exit | BENITEC BIOPHARMA INC | $0 | – | -658,796 | -100.0% | -0.09% | – |
| Exit | AMYLYX PHARMACEUTICALS INCput | $0 | – | -9,000 | -100.0% | -0.09% | – | |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -8,500 | -100.0% | -0.12% | – |
| TTOO | Exit | T2 BIOSYSTEMS INC | $0 | – | -2,840,000 | -100.0% | -0.12% | – |
| PALI | Exit | PALISADE BIO INC | $0 | – | -5,643,007 | -100.0% | -0.20% | – |
| GRIL | Exit | MUSCLE MAKER INC | $0 | – | -1,771,331 | -100.0% | -0.24% | – |
| Exit | RELMADA THERAPEUTICS INCput | $0 | – | -18,200 | -100.0% | -0.25% | – | |
| Exit | CLENE INCput | $0 | – | -281,500 | -100.0% | -0.29% | – | |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -51,000 | -100.0% | -0.31% | – |
| Exit | RENOVACOR INC | $0 | – | -388,845 | -100.0% | -0.36% | – | |
| OMEG | Exit | OMEGA ALPHA SPACcl a | $0 | – | -100,000 | -100.0% | -0.36% | – |
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -100,000 | -100.0% | -0.37% | – |
| Exit | RELATIVITY ACQUISITION CORPunit 02/10/2027 | $0 | – | -100,000 | -100.0% | -0.37% | – | |
| Exit | INDUSTRIAL HUMAN CAPITAL INC | $0 | – | -100,000 | -100.0% | -0.37% | – | |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -320,000 | -100.0% | -0.38% | – |
| Exit | DIGITAL HEALTH ACQUISITION Cunit 11/02/2026 | $0 | – | -150,000 | -100.0% | -0.57% | – | |
| ALKS | Exit | ALKERMES PLC | $0 | – | -70,000 | -100.0% | -0.57% | – |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -60,000 | -100.0% | -0.57% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -135,000 | -100.0% | -0.59% | – |
| TRVI | Exit | TREVI THERAPEUTICS INC | $0 | – | -1,066,157 | -100.0% | -0.60% | – |
| Exit | HILLMAN SOLUTIONS CORP | $0 | – | -221,000 | -100.0% | -0.61% | – | |
| UBX | Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -4,270,000 | -100.0% | -0.62% | – |
| MDWD | Exit | MEDIWOUND LTD | $0 | – | -1,276,948 | -100.0% | -0.65% | – |
| EYPT | Exit | EYEPOINT PHARMACEUTICALS INC | $0 | – | -224,541 | -100.0% | -0.65% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -80,000 | -100.0% | -0.68% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -900,000 | -100.0% | -0.68% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -105,000 | -100.0% | -0.72% | – |
| JYAC | Exit | JIYA ACQUISITION CORP | $0 | – | -200,000 | -100.0% | -0.73% | – |
| Exit | LAKESHORE ACQUISITION II CORordinary shares | $0 | – | -200,000 | -100.0% | -0.74% | – | |
| Exit | 2SEVENTY BIO INC | $0 | – | -140,000 | -100.0% | -0.75% | – | |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -12,000 | -100.0% | -0.78% | – |
| ACET | Exit | ADICET BIO INC | $0 | – | -150,000 | -100.0% | -0.78% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -517,133 | -100.0% | -0.79% | – |
| SRSA | Exit | SARISSA CAPITAL ACQUISITN COcl a | $0 | – | -225,000 | -100.0% | -0.82% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -68,000 | -100.0% | -0.88% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -150,000 | -100.0% | -0.90% | – |
| TMPM | Exit | TURMERIC ACQUISITION CORPcl a | $0 | – | -254,000 | -100.0% | -0.93% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -3,000,000 | -100.0% | -0.94% | – |
| LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -42,000 | -100.0% | -1.08% | – |
| ATEC | Exit | ALPHATEC HLDGS INC | $0 | – | -342,000 | -100.0% | -1.10% | – |
| NTRA | Exit | NATERA INC | $0 | – | -75,000 | -100.0% | -1.20% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -88,000 | -100.0% | -1.21% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -440,000 | -100.0% | -1.22% | – |
| Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -81,000 | -100.0% | -1.23% | – | |
| INGN | Exit | INOGEN INC | $0 | – | -146,000 | -100.0% | -1.30% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -66,000 | -100.0% | -1.30% | – |
| Exit | QUIDELORTHO CORP | $0 | – | -50,000 | -100.0% | -1.31% | – | |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -280,000 | -100.0% | -1.31% | – |
| ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -195,000 | -100.0% | -1.46% | – |
| EUCR | Exit | EUCRATES BIOMEDICAL ACQU COR | $0 | – | -400,000 | -100.0% | -1.47% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -750,000 | -100.0% | -1.50% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -22,000 | -100.0% | -1.54% | – |
| BCAB | Exit | BIOATLA INC | $0 | – | -553,000 | -100.0% | -1.56% | – |
| MBTC | Exit | NOCTURNE ACQUISITION CORPordinary shares | $0 | – | -500,000 | -100.0% | -1.89% | – |
| Exit | GUARDANT HEALTH INCcall | $0 | – | -100,000 | -100.0% | -1.97% | – | |
| INSM | Exit | INSMED INC | $0 | – | -268,000 | -100.0% | -2.12% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -160,000 | -100.0% | -3.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.